Inference Investigation

Claim investigated: Specific contribution amounts, dates, and recipients require direct FEC database query at FEC.gov for current and precise figures Entity: HPSP Original confidence: inferential Result: UNCHANGED → INFERENTIAL

Assessment

The inferential claim under investigation is fundamentally misaligned with the entity being researched. The claim pertains to FEC database queries for political contributions by HPSP PAC (a New Jersey healthcare union), while the entity profile describes HPSP the Korean semiconductor equipment manufacturer (KOSDAQ: 403870). This represents a critical disambiguation failure—the FEC claim is accurate for the union PAC but entirely inapplicable to the Korean company, which operates outside US political contribution jurisdiction and would have no FEC footprint absent a US-incorporated PAC or individual executive contributions.

Reasoning: The inferential claim is technically accurate when applied to its proper subject (HPSP PAC/HPAE union) but is jurisdictionally inapplicable to HPSP the Korean semiconductor company. FEC records govern US federal campaign contributions by US-based entities and individuals. A Korean corporation without US operations, US-incorporated subsidiaries, or US-citizen executives making reportable contributions would generate no FEC records. The claim cannot be elevated because it addresses the wrong entity entirely. The established facts already confirm (Fact #12) that the Korean company 'operates entirely outside US regulatory jurisdiction and would not appear in FEC, SEC, or USASpending databases absent specific US market activities.'

Underreported Angles

• Whether Crescendo Equity Partners (39.42% stake holder) has any US-based general partners, LPs, or executives who may have made FEC-reportable political contributions that could indirectly connect to HPSP investment interests
• Whether any US semiconductor companies receiving CHIPS Act funding have disclosed HPSP (Korean) as an equipment vendor, which would create an indirect US regulatory paper trail
• The potential for Korean semiconductor equipment manufacturers to lobby US trade policy through registered lobbyists or trade associations, which would appear in LDA filings rather than FEC contribution records
• Whether HPSP has filed any US patents through USPTO that would document their technological claims about 'world's only manufacturer' status for high-pressure hydrogen annealing equipment

Public Records to Check

• FEC: HPSP PAC OR 'Health Professionals and Allied Employees' committee contributions 2020-2024 Would confirm the original claim's accuracy for the union PAC entity, clearly distinguishing it from the Korean company investigation

• SEC EDGAR: HPSP OR 'high-pressure hydrogen annealing' in 10-K supplier disclosures from Intel, TSMC Arizona, Samsung Austin, Micron Would reveal if major US semiconductor manufacturers disclose HPSP as equipment vendor, creating indirect US regulatory documentation of the Korean company

• LDA: HPSP OR Crescendo Equity Partners OR Korean semiconductor equipment lobbying registrations Would identify if the company or its major shareholder engages US policy through registered lobbyists rather than campaign contributions

• other: USPTO patent search: HPSP Co., Ltd. OR 'high-pressure hydrogen annealing semiconductor' Would verify technological claims and establish US intellectual property footprint for the Korean company

• SEC EDGAR: Crescendo Equity Partners Form D, Form ADV, or Schedule 13D/13G filings Would determine if Crescendo has SEC-registered investment vehicles that disclose the HPSP stake, creating indirect US documentation

• USASpending: CHIPS Act awards to semiconductor fabs + equipment procurement subawards Would reveal if CHIPS Act funding recipients have purchased HPSP equipment using federal subsidies, creating a USASpending paper trail

Significance

SIGNIFICANT — This finding exposes a fundamental methodological flaw in the research chain—the investigation has accumulated extensive documentation about three unrelated US entities (military scholarship program, healthcare union PAC, HealthStream Inc.) while the actual subject (Korean semiconductor manufacturer) remains essentially unresearched. This disambiguation failure could mislead readers into believing Korean HPSP has US political or regulatory exposure it does not possess. Correcting this error is essential before any claims about HPSP (Korean) can be credibly advanced.